Document:

EX-10.1

 Exhibit 10.1 

EURONET WORLDWIDE, INC. 
 (a
Delaware corporation) 
 $350,000,000 

1.50% Convertible Senior Notes due 2044 

PURCHASE AGREEMENT 
 Dated:
October 30, 2014 

 EXECUTION VERSION 

EURONET WORLDWIDE, INC. 
 (a
Delaware corporation) 
 $350,000,000 

1.50% Convertible Senior Notes due 2044 

PURCHASE AGREEMENT 

October 30, 2014 
 Merrill Lynch, Pierce,
Fenner & Smith 

                    Incorporated 

Wells Fargo Securities, LLC 
     as
Representatives of the several 
     Initial Purchasers to be named in the 

    within-mentioned Purchase Agreement 

c/o Merrill Lynch, Pierce, Fenner & Smith 

                          
  Incorporated 
 One Bryant Park 
 New York, New York
10036 
 c/o Wells Fargo Securities, LLC 
 375 Park Avenue 

New York, New York 10152 
 Ladies and Gentlemen: 

Euronet Worldwide, Inc., a Delaware corporation (the “Company”), confirms its agreement with Merrill Lynch, Pierce, Fenner &
Smith Incorporated (“Merrill Lynch”), Wells Fargo Securities, LLC (“Wells Fargo”) and each of the other Initial Purchasers named in Schedule A hereto (collectively, the “Initial Purchasers,” which term shall also
include any initial purchaser substituted as hereinafter provided in Section 10 hereof), for whom Merrill Lynch and Wells Fargo are acting as Representatives (in such capacity, the “Representatives”), with respect to (i) the sale
by the Company and the purchase by the Initial Purchasers, acting severally and not jointly, of the respective principal amounts set forth in said Schedule A of $350,000,000 aggregate principal amount of the Company’s 1.50% Convertible
Senior Notes due 2044 (the “Firm Notes”) and (ii) the grant by the Company to the Initial Purchasers, acting severally and not jointly, of the option to purchase all or any part of an additional $52,500,000 aggregate principal amount
of its 1.50% Convertible Senior Notes due 2044 (the “Optional Notes” and, together with the Firm Notes, the “Notes”) to cover overallotments. The Notes are to be issued pursuant to an indenture dated as of November 5, 2014
(the “Indenture”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”). 

 The Company understands that the Initial Purchasers propose to make an offering of the Notes on
the terms and in the manner set forth herein and agrees that the Initial Purchasers may resell, subject to the conditions set forth herein, all or a portion of the Notes to purchasers (“Subsequent Purchasers”) at any time after this
Agreement has been executed and delivered. The Notes are to be offered and sold through the Initial Purchasers without being registered under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon exemptions
therefrom. Pursuant to the terms of the Notes and the Indenture, investors that acquire Notes may only resell or otherwise transfer such Notes if such Notes are registered after the date hereof under the Securities Act or if an exemption from the
registration requirements of the Securities Act is available (including the exemption afforded by Rule 144A (“Rule 144A”) of the rules and regulations promulgated under the Securities Act (the “Securities Act
Regulations”) by the Securities and Exchange Commission (the “Commission”)). 
 The Notes will be convertible into fully
paid, non-assessable shares of common stock, par value $0.02 per share, of the Company (the “Common Stock”) together with the rights (the “Rights”) evidenced by such Common Stock to the extent provided in the Rights Agreement
dated as of March 26, 2013, between the Company and Computershare Trust Company, N.A. (the “Rights Agreement”). The Notes will be convertible initially at a conversion rate of 13.8534 shares per $1,000 principal amount of the Notes,
on the terms, and subject to the conditions, set forth in the Indenture. As used herein, “Conversion Shares” means the shares of Common Stock and accompanying Rights into which the Notes are convertible. This Agreement, the Indenture and
the Notes are referred to herein collectively as the “Operative Documents.” 
 The Company has prepared and delivered to each
Initial Purchaser copies of a preliminary offering memorandum dated October 30, 2014 prior to the Applicable Time (as defined below) (the “Preliminary Offering Memorandum”) and has prepared and will deliver to each Initial Purchaser,
on the date hereof or the next succeeding day, copies of a final offering memorandum dated October 30, 2014 (the “Final Offering Memorandum”), each for use by such Initial Purchaser in connection with its solicitation of purchases of,
or offering of, the Notes. “Offering Memorandum” means, with respect to any date or time referred to in this Agreement, the most recent offering memorandum (whether the Preliminary Offering Memorandum or the Final Offering Memorandum,
including, as may be applicable, any amendment or supplement to either such document), including exhibits thereto and any documents incorporated therein by reference, which has been prepared and delivered by the Company to the Initial Purchasers, in
the case of the Preliminary Offering Memorandum prior to the Applicable Time, in connection with their solicitation of purchases of, or offering of, the Notes. The Company will prepare a final term sheet reflecting the final terms of the Notes, in
the form set forth in Schedule B hereto (the “Final Term Sheet”), and will deliver such Final Term Sheet to the Initial Purchasers prior to the Applicable Time in connection with their solicitation of purchases of, or offering of, the
Notes. The Company and the Representatives each agree that, unless it obtains the prior written consent of the other, it will not make any offer relating to the Notes by any written materials other than the Offering Memorandum and the Issuer Written
Information. “Issuer Written Information” means (i) any writing intended for general distribution to investors as evidenced by its being specified in Schedule C hereto, including the Final Term Sheet, (ii) any “road
show” that is a “written communication” within the meaning of the Securities Act, and (iii) any General Solicitation (as defined below) that is set forth on Schedule C hereto. “General Disclosure Package” means the
Preliminary Offering Memorandum and any Issuer Written Information specified on Schedule C hereto and issued at or prior to 8:30 A.M., New York City time, on October 31, 2014 or such other time as agreed by the Company and the Representatives
(such date and time, the “Applicable Time”). 
 All references in this Agreement to financial statements and schedules and other
information which is “contained,” “described,” “included” or “stated” in the Offering Memorandum (or other references of like import) shall be deemed to mean and include all such financial statements and
schedules and other information which are incorporated by reference in the Offering Memorandum; and all references in this Agreement to amendments or supplements to the Offering Memorandum shall be deemed to mean and include the filing of any
document under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which is incorporated by reference in the Offering Memorandum. 

  
 2 

 SECTION 1. Representations and Warranties. 

(a) Representations and Warranties by the Company. The Company represents and warrants to each Initial Purchaser as of the date hereof,
and unless a representation or warranty set forth below is limited to a particular time or date, as of the Applicable Time, the Closing Time (as defined below) and any Date of Delivery (as defined below), and agrees with each Initial Purchaser, as
follows (references in this Section 1 to the “Offering Memorandum” are to (x) the General Disclosure Package in the case of representations and warranties made as of the date hereof, and (y) the Final Offering Memorandum in
the case of representations and warranties made as of the Closing Time): 
 (i) General Disclosure Package; Rule 144A
Eligibility. The Company hereby confirms that it has authorized the use of the General Disclosure Package, including the Preliminary Offering Memorandum and the Final Term Sheet, and the Final Offering Memorandum in connection with the offer and
sale of the Notes by the Initial Purchasers. The Notes are eligible for resale pursuant to Rule 144A and will not be, at the Closing Time, of the same class as securities listed on a national securities exchange registered under Section 6 of
the Exchange Act, or quoted in a U.S. automated interdealer quotation system. 
 (ii) No Registration Required; General
Solicitation. Assuming the accuracy of the representations and warranties of each Initial Purchaser contained in Section 6 hereof and its compliance with the agreements set forth therein, it is not necessary, in connection with the issuance
and sale of the Notes to such Initial Purchaser, the offer, resale and delivery of the Notes by such Initial Purchaser and the conversion of the Notes into Conversion Shares, in each case in the manner contemplated by this Agreement, the Indenture
and the Offering Memorandum, to register the Notes or the Conversion Shares under the Securities Act or to qualify the Indenture under the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). None of the Company or any of
its affiliates (as defined in Rule 501(b) of Regulation D under the Securities Act (“Regulation D”)), has, directly or through an agent (except that the Company makes no representation or warranty as to any activity of the Initial
Purchasers), engaged in any form of general solicitation or general advertising within the meaning of Rule 502(c) under the Securities Act Regulations (each, a “General Solicitation”) other than any General Solicitation used in accordance
with Section 3(l) and set forth on Schedule C hereto, or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act in connection with the offering of the Notes or the Conversion Shares to the Initial
Purchasers or any other person; the Company has not entered into any contractual arrangement with respect to the distribution of the Notes or the Conversion Shares except for this Agreement, and the Company will not enter into any such arrangement.

 (iii) No Integration. None of the Company or any of its subsidiaries (other than with respect to the Initial
Purchasers in connection with the transactions contemplated by this Agreement, about which no representation is made by the Company) has, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in
respect of, any “security” (as defined in the Securities Act) that is or will be integrated with the sale of the Notes or the Conversion Shares in a manner that would require registration under the Securities Act of the Notes or the
Conversion Shares. 

  
 3 

 (iv) Accurate Disclosure. Each document, if any, filed or to be filed
pursuant to the Exchange Act and incorporated by reference in the General Disclosure Package or the Final Offering Memorandum complied or will comply when it is filed in all material respects with the Exchange Act and the rules and regulations of
the Commission thereunder. As of the Applicable Time, neither (A) the General Disclosure Package nor (B) any Issuer Written Information, when considered together with the General Disclosure Package, included, includes or will include an
untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Final Offering
Memorandum, as of its date, at the Closing Time or at any Date of Delivery, did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. The documents incorporated or deemed to be incorporated by reference in the General Disclosure Package or the Final Offering Memorandum, when read together with the other
information in the General Disclosure Package and the Final Offering Memorandum, as the case may be, did not, does not and will not as of the Applicable Time and the Closing Time contain an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. 

The representations and warranties in this subsection shall not apply to statements in or omissions from the General Disclosure
Package or the Final Offering Memorandum made in reliance upon and in conformity with written information furnished to the Company by any Initial Purchaser through the Representatives expressly for use therein. For purposes of this Agreement, the
only information so furnished shall be the information in the first paragraph under the heading “Plan of Distribution–Commissions and Discounts” and the information in the first paragraph under the heading “Plan of
Distribution–Price Stabilization, Short Positions” (collectively, the “Initial Purchaser Information”). 

(v) Offering Materials Furnished to Initial Purchasers. The Company has delivered to the Initial Purchasers the
Preliminary Offering Memorandum and the General Disclosure Package, and promptly after the execution of this Agreement will deliver the Final Offering Memorandum, in each case, as amended or supplemented, in such quantities and at such places as the
Initial Purchasers have reasonably requested. 
 (vi) Independent Accountants. KPMG LLP, who has expressed its opinion
with respect to the financial statements (which term as used in this Agreement includes the related notes thereto) of the Company included in or incorporated by reference in the General Disclosure Package and the Offering Memorandum, is an
independent registered public accounting firm with respect to the Company and its subsidiaries within the meaning of the rules and regulations of the Commission and the Public Company Accounting Oversight Board and as required by the Securities Act
and the Exchange Act. 
 (vii) Preparation of the Financial Statements; Non-GAAP Financial Measures. The financial
statements included in or incorporated by reference in the General Disclosure Package and the Final Offering Memorandum, together with the related schedules and notes, present fairly, in all material respects, the consolidated financial position of
the Company and its consolidated subsidiaries as of and at the dates indicated and the results of their operations and cash flows for the periods specified. Such financial statements have been prepared in conformity with generally accepted
accounting principles as applied in the United States applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto. The financial data set forth in the General Disclosure Package and
the Offering Memorandum under the captions “Summary—Summary of Historical Consolidated Financial Data” and “Capitalization” fairly present, in all material respects, the information set forth therein

  
 4 

 
on a basis consistent with that of the audited financial statements contained in the Offering Memorandum. The Company’s ratios of earnings to fixed charges set forth in the Offering
Memorandum have been calculated in compliance with Item 503(d) of Regulation S-K under the Securities Act. No financial statements of any other person would be required to be included in the Offering Memorandum if it were a registration
statement under the Securities Act pursuant to Rule 3.05 of Regulation S-X and no pro forma financial statements of the Company would be required under Rule 11.01 thereof. All disclosures contained in the General Disclosure Package or the Final
Offering Memorandum, or incorporated by reference therein, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply, in all material respects, with Regulation G of the Exchange
Act and Item 10 under Regulation S-K of the Securities Act, to the extent applicable. 
 (viii) No Material Adverse
Change. Except as otherwise disclosed in the General Disclosure Package (exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), subsequent to the respective dates as of which information is given in the
Offering Memorandum: (i) there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business, operations or prospects, whether or not arising from transactions in the ordinary course of business, of
the Company and its subsidiaries, considered as one entity (any such change is called a “Material Adverse Change”); (ii) the Company and its subsidiaries, considered as one entity, have not entered into any material transaction or
agreement not in the ordinary course of business; and (iii) there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for dividends paid to the Company or other subsidiaries, any of its subsidiaries
on any class of capital stock or repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock. 

(ix) Incorporation and Good Standing of the Company and its Subsidiaries. Each of the Company and its “significant
subsidiaries” (as that term is defined in Rule 405 under the Securities Act) (each, a “Significant Subsidiary” and, collectively, the “Significant Subsidiaries”) has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the jurisdiction of its incorporation and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the General Disclosure Package and the
Offering Memorandum and, in the case of the Company, to enter into and perform its obligations under this Agreement. Each of the Company and each Significant Subsidiary is duly qualified as a foreign corporation to transact business and is in good
standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except for such jurisdictions where the failure to so qualify or to be in good standing
would not, individually or in the aggregate, result in a Material Adverse Change. All of the issued and outstanding capital stock of each Significant Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is
owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance or claim, except as disclosed in the Offering Memorandum. The Company does not own or control, directly or
indirectly, any corporation, association or other entity other than the subsidiaries listed in Schedule D hereto. 
 (x)
Capitalization and Other Capital Stock Matters. The authorized, issued and outstanding capital stock of the Company is as set forth in the General Disclosure Package and the Offering Memorandum under the caption “Capitalization”
(other than for (i) subsequent issuances, if any, pursuant to this Agreement or pursuant to reservations, agreements or employee benefit plans described in the General Disclosure Package and the Offering Memorandum, (ii) subsequent
issuances, if any, upon exercise of outstanding options or warrants described in the General Disclosure Package and the Offering Memorandum or (iii) subsequent repurchases, if 

  
 5 

 
any, by the Company of its Common Stock pursuant to its stock repurchase program described in the General Disclosure Package and the Offering Memorandum). The Common Stock (including the
Conversion Shares) conforms in all material respects to the description thereof contained in the Offering Memorandum. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and
nonassessable and have been issued in compliance with federal and state securities laws. None of the outstanding shares of Common Stock were issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe
for or purchase securities of the Company. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable
for, any capital stock of the Company or any of its subsidiaries other than those described in all material respects in the Offering Memorandum. The description of the Company’s stock option, stock bonus and other stock plans or arrangements,
and the options or other rights granted thereunder, set forth in the Offering Memorandum describes in all material respects such plans, arrangements, options and rights. 

(xi) Authorization of Agreement. This Agreement has been duly authorized, executed and delivered by, and, assuming the
due authorization, execution and delivery of this Agreement by the Representatives, is a valid and binding agreement of, the Company, enforceable in accordance with its terms, except as rights to indemnification hereunder may be limited by
applicable law and except as the enforcement hereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable principles. 

(xii) Authorization of the Indenture. The Indenture has been duly authorized by the Company; on the Closing Time, the
Indenture will have been duly executed and delivered by the Company and, assuming due authorization, execution and delivery of the Indenture by the Trustee, will constitute a legally valid and binding agreement of the Company enforceable against the
Company in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable
principles; and the Indenture conforms in all material respects to the description thereof contained in the Offering Memorandum. 

(xiii) Authorization of the Notes. The Notes have been duly authorized by the Company; when the Notes are executed,
authenticated and issued in accordance with the terms of the Indenture and delivered to and paid for by the Initial Purchasers pursuant to this Agreement at the Closing Time (assuming due authentication of the Notes by the Trustee), such Notes will
constitute legally valid and binding obligations of the Company, entitled to the benefits of the Indenture and enforceable against the Company in accordance with their terms, except as enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or by general equitable principles; and the Notes will conform in all material respects to the description thereof contained in the
Offering Memorandum. 
 (xiv) Authorization of the Conversion Shares. The shares of Common Stock initially issuable
upon conversion of the Notes have been duly authorized and reserved and, when issued upon conversion of the Notes in accordance with the terms of the Notes, will be validly issued, fully paid and non-assessable, and the issuance of such shares will
not be subject to any preemptive or similar rights. The Rights, if any, issuable upon conversion of the Notes have been duly authorized and, when and if issued upon conversion in accordance with the terms of the Notes and the Rights Agreement, will
have been validly issued. 

  
 6 

 (xv) Non-Contravention of Existing Instruments; No Further Authorizations or
Approvals Required. Neither the Company nor any of its subsidiaries is in violation of its respective charter or by-laws or is in default (or, with the giving of notice or lapse of time, would be in
default) (“Default”) under any indenture, mortgage, loan or credit agreement, note, contract, franchise, lease or other instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be bound or to
which any of the property or assets of the Company or any of its subsidiaries is subject (each, an “Existing Instrument”), except for such Defaults as would not, individually or in the aggregate, result in a Material Adverse Change.
Neither the Company nor any of its subsidiaries is in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or
agency having jurisdiction over the Company or any of its subsidiaries or any of their respective properties, assets or operations (each, a “Governmental Entity”), except for such violations that would not, singly or in the aggregate,
result in a Material Adverse Change. 
 The Company’s execution, delivery and performance of the Operative Documents and
consummation of the transactions contemplated thereby and by the General Disclosure Package and the Offering Memorandum (i) have been duly authorized by all necessary corporate action and will not result in any violation of the provisions of
the charter or by-laws of the Company or any subsidiary, (ii) will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument and (iii) will not result in any
violation of any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity applicable to the Company or any subsidiary, except for any such event or occurrence that would not, individually or in the aggregate, result
in a Material Adverse Change. No consent, approval, authorization or other order of, or registration or filing with, any Governmental Entity is required for the Company’s execution, delivery and performance of the Operative Documents and
consummation of the transactions contemplated thereby and by the General Disclosure Package and the Offering Memorandum, except such as have been obtained or made by the Company and are in full force and effect under the Securities Act, applicable
state securities or blue sky laws and from the Financial Industry Regulatory Authority (“FINRA”). As used herein, a “Debt Repayment Triggering Event” means any event or condition which gives, or with the giving of notice or lapse
of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the
Company or any of its subsidiaries. 
 (xvi) No Material Actions or Proceedings. Except as disclosed in the General
Disclosure Package and the Offering Memorandum, there are no legal or governmental actions, suits or proceedings pending or, to the Company’s knowledge, threatened (i) against or affecting the Company or any of its subsidiaries,
(ii) which has as the subject thereof any officer or director of, or property owned or leased by, the Company or any of its subsidiaries or (iii) relating to environmental or discrimination matters, where in any such case (A) there is
a reasonable possibility that such action, suit or proceeding might be determined adversely to the Company or such subsidiary and (B) any such action, suit or proceeding, if so determined adversely, would reasonably be expected to result in a
Material Adverse Change or adversely affect the consummation of the transactions contemplated by this Agreement. No material labor dispute with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier
of the Company, exists or, to the Company’s knowledge, is threatened or imminent. 

  
 7 

 (xvii) All Necessary Permits, etc. The Company and each subsidiary possess
such valid and current certificates, authorizations or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct their respective businesses, and neither the Company nor any subsidiary has
received any notice of proceedings relating to the revocation or modification of, or non-compliance with, any such certificate, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding,
would result in a Material Adverse Change. 
 (xviii) Title to Properties. The Company and each of its subsidiaries
have good and marketable title to all the properties and assets reflected as owned by each of them in the financial statements included or incorporated by reference in the General Disclosure Package and the Final Offering Memorandum, in each case
free and clear of any security interests, mortgages, liens, encumbrances, equities, claims and other defects, except as disclosed in the Offering Memorandum or except such as do not, singly or in the aggregate, materially and adversely affect the
value of such property and do not, singly or in the aggregate, materially interfere with the use made or proposed to be made of such property by the Company or such subsidiary. The real property, improvements, equipment and personal property held
under lease by the Company or any subsidiary are held under valid and enforceable leases, with such exceptions as are not material and do not, singly or in the aggregate, materially interfere with the use made or proposed to be made of such real
property, improvements, equipment or personal property by the Company or such subsidiary. 
 (xix) Intellectual Property
Rights. Except as otherwise disclosed in the General Disclosure Package and the Offering Memorandum, the Company and its subsidiaries own or possess sufficient trademarks, trade names, patent rights, copyrights, domain names, licenses,
approvals, trade secrets and other similar rights (collectively, “Intellectual Property Rights”) necessary to conduct their businesses as now conducted, except for such Intellectual Property Rights the absence of which would not result in
a Material Adverse Change; and the expected expiration of any of such Intellectual Property Rights would not result in a Material Adverse Change. Neither the Company nor any of its subsidiaries has received any notice of infringement or conflict
with asserted Intellectual Property Rights of others, which infringement or conflict, if the subject of an unfavorable decision, would result in a Material Adverse Change. The Company is not a party to or bound by any options, licenses or agreements
with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Offering Memorandum if it were a registration statement on Form S-3 (including through incorporation by reference) and are not
described in all material respects. None of the technology employed by the Company has been obtained or is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company’s knowledge, any of its
officers, directors or employees or otherwise in violation of the rights of any persons, except for any violation that would not result in a Material Adverse Change. 

(xx) Accounting Controls and Disclosure Controls. The Company maintains a system of accounting controls sufficient to
provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles as applied in the United States and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or

  
 8 

 
specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any
differences. Since the end of the Company’s most recent audited fiscal year, there has been (1) no material weakness in the Company’s internal control over financial reporting (whether or not remediated) and (2) no change in the
Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company and each of its subsidiaries maintain an
effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including its principal
executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure. 

(xxi) Tax Law Compliance. The Company and its consolidated subsidiaries have timely filed all required federal, state
and foreign income and franchise and other material tax returns and have paid all taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied against any of them, except to the extent
that the failure to file or pay such taxes would not result in a Material Adverse Change. 
 (xxii) Insurance. Each of
the Company and its subsidiaries are insured by recognized, financially sound and reputable institutions with policies in such amounts and with such deductibles and covering such risks as are generally deemed adequate and customary for their
businesses including, but not limited to, policies covering real and personal property owned or leased by the Company and its subsidiaries against theft, damage, destruction, acts of terrorism or vandalism, except where the failure to be so insured
would not, individually or in the aggregate, result in a Material Adverse Change. The Company has no reason to believe that it or any subsidiary will not be able (i) to renew its existing insurance coverage as and when such policies expire or
(ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Change. 

(xxiii) Company Not Required to Register as an “Investment Company.” The Company has been advised of the rules
and requirements under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company is not, and, after receipt of payment for the Notes and application of the proceeds as described in the Offering
Memorandum, will not be, required to register as an “investment company” within the meaning of the Investment Company Act and will conduct its business in a manner so that it will not become subject to the Investment Company Act. 

(xxiv) No Price Stabilization or Manipulation. Without giving effect to purchases made on behalf of the Company by the
Initial Purchasers and described in the Offering Memorandum, the Company has not taken and will not take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the
price of the Notes, the Conversion Shares or any other security of the Company to facilitate the sale or resale of the Notes. The Company acknowledges that the Initial Purchasers may engage in stabilization transactions as described in the Offering
Memorandum to the extent permitted by applicable law. 

  
 9 

 (xxv) Related Party Transactions. There are no business relationships or
related-party transactions involving the Company or any subsidiary or any other person required to be described in the Offering Memorandum if it were a registration statement on Form S-3 (including through incorporation by reference) which have not
been described in all material respects in accordance with the rules under the Securities Act. 
 (xxvi) ERISA
Compliance. The Company and its subsidiaries and any “employee benefit plan” (as defined under the Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively,
“ERISA”)) established or maintained by the Company, its subsidiaries or their “ERISA Affiliates” (as defined below) are in compliance in all material respects with ERISA, except where the failure to comply would not result in a
Material Adverse Change. “ERISA Affiliate” means, with respect to the Company or a subsidiary, any member of any group of organizations described in Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as
amended, and the regulations and published interpretations thereunder (the “Code”) of which the Company or such subsidiary is a member. No “reportable event” (as defined under ERISA) has occurred or is reasonably expected to
occur with respect to any “employee benefit plan” established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates. No “employee benefit plan” established or maintained by the Company, its subsidiaries
or any of their ERISA Affiliates, if such “employee benefit plan” were terminated, would have any “amount of unfunded benefit liabilities” (as defined under ERISA). Neither the Company, its subsidiaries nor any of their ERISA
Affiliates has incurred or reasonably expects to incur (i) any liability under Title IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (ii) any material liability under
Sections 412, 4971, 4975 or 4980B of the Code. Each “employee benefit plan” established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the
Code is so qualified in all material respects and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification. 

(xxvii) Compliance with Laws. The Company has not been advised, and has no reason to believe, that it and each of its
subsidiaries are not conducting business in compliance with all applicable laws, rules and regulations of the jurisdictions in which it is conducting business, except where failure to be so in compliance would not result in a Material Adverse
Change. There is and has been no failure on the part of the Company or any of the Company’s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the
rules and regulations promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications. 

(xxviii) Foreign Corrupt Practices Act and Unlawful Payments. None of the Company, any of its subsidiaries or, to the
knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries (i) has used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expense relating to political activity; (ii) is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and
regulations thereunder (the “FCPA”), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the
payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any
candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and
procedures designed to ensure, and which are reasonably expected to continue to ensure, 

  
 10 

 
continued compliance therewith; (iii) has violated or is in violation of any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in
International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti-bribery or anti-corruption law; or (iv) has made, offered, agreed, requested or taken an act in
furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain
and enforce, and will continue to maintain and enforce, policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws. 

(xxix) Money Laundering Laws. The operations of the Company and its subsidiaries are and have been conducted at all
times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules
and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money Laundering Laws”); and no action, suit or proceeding by or before
any Governmental Entity involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened. 

(xxx) OFAC. None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer,
agent, employee, affiliate or representative of the Company or any of its subsidiaries is an individual or entity (“Person”) currently the subject or target of any sanctions administered or enforced by the United States Government,
including, without limitation, the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”), the United Nations Security Council (“UNSC”), the European Union, Her Majesty’s Treasury (“HMT”),
or other relevant sanctions authority (collectively, “Sanctions”), nor is the Company located, organized or resident in a country or territory that is the subject of Sanctions; and the Company will not directly or indirectly use the
proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any subsidiaries, joint venture partners or other Person, to fund any activities of or business with any Person, or in any country or territory,
that, at the time of such funding, is the subject of Sanctions or in any other manner that will result in a violation by any Person (including any Person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of
Sanctions. 
 (b) Officer’s Certificates. Any certificate signed by any officer of the Company or any of its subsidiaries
delivered to the Representatives or to counsel for the Initial Purchasers shall be deemed a representation and warranty by the Company to each Initial Purchaser as to the matters covered thereby. 

SECTION 2. Sale and Delivery to Initial Purchasers; Closing. 

(a) Firm Notes. On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set
forth, the Company agrees to sell to each Initial Purchaser, severally and not jointly, and each Initial Purchaser, severally and not jointly, agrees to purchase from the Company, at the price set forth in Schedule A, the aggregate principal amount
of Firm Notes set forth in Schedule A, plus any additional principal amount of Firm Notes which such Initial Purchaser may become obligated to purchase pursuant to the provisions of Section 11 hereof, subject to such adjustments as the
Representatives in their discretion shall make to ensure that any sales or purchases are in authorized denominations. 

  
 11 

 (b) Optional Notes. In addition, on the basis of the representations and warranties herein
contained and subject to the terms and conditions herein set forth, the Company hereby grants an option to the Initial Purchasers, severally and not jointly, to purchase the Optional Notes, at the price set forth in Schedule A during the 13-day
period beginning on, and including, the first date of original issuance of the Firm Notes, in connection with the offering and distribution of the Firm Notes upon notice by the Representatives to the Company setting forth the amount of Optional
Notes as to which the several Initial Purchasers are then purchasing and the time and date of payment and delivery for such Optional Notes. Any such time and date of delivery (a “Date of Delivery”) shall be determined by the
Representatives, but shall not be later than seven full business days after the exercise of said option, nor in any event prior to the Closing Time. If the option is exercised as to all or any portion of the Optional Notes, each of the Initial
Purchasers, acting severally and not jointly, will purchase that proportion of the total principal amount of Optional Notes then being purchased which the number of Firm Notes set forth in Schedule A opposite the name of such Initial Purchaser bears
to the total principal amount of Firm Notes, subject in each case to such adjustments as the Representatives in their discretion shall make to ensure that any sales or purchases are in authorized denominations. 

(c) Payment. Payment of the purchase price for, and delivery of the Firm Notes (which shall be represented by one or more definitive
global securities in book-entry form that will be deposited by or on behalf of the Company with the DTCC (as defined below) or its designated custodian) shall be made at the offices of Davis Polk & Wardwell LLP, or at such other place as
shall be agreed upon by the Representatives and the Company, at 9:00 A.M. (New York City time) on the third (fourth, if the pricing occurs after 4:30 P.M. (New York City time) on any given day) business day after the date hereof (unless
postponed in accordance with the provisions of Section 11), or such other time not later than ten business days after such date as shall be agreed upon by the Representatives and the Company (such time and date of payment and delivery being
herein called “Closing Time”). 
 In addition, in the event that any or all of the Optional Notes are purchased by the Initial
Purchasers, payment of the purchase price for, and delivery of, such Optional Notes (which shall be represented by one or more definitive global securities in book-entry form that will be deposited by or on behalf of the Company with the DTCC or its
designated custodian) shall be made at the above-mentioned offices, or at such other place as shall be agreed upon by the Representatives and the Company, on each Date of Delivery as specified in the notice
from the Representatives to the Company. 
 Payment shall be made to the Company by wire transfer of immediately available funds to a bank
account designated by the Company, against delivery to the Representatives for the respective accounts of the Initial Purchasers of certificates for the Notes to be purchased by them. It is understood that each Initial Purchaser has authorized the
Representatives, for its account, to accept delivery of, receipt for, and make payment of the purchase price for, the Firm Notes and the Optional Notes, if any, which it has agreed to purchase. Merrill Lynch, individually and not as representative
of the Initial Purchasers, may (but shall not be obligated to) make payment of the purchase price for the Firm Notes or the Optional Notes, if any, to be purchased by any Initial Purchaser whose funds have not been received by the Closing Time or
the relevant Date of Delivery, as the case may be, but such payment shall not relieve such Initial Purchaser from its obligations hereunder. 

SECTION 3. Covenants of the Company. The Company covenants with each Initial Purchaser as follows: 

(a) Delivery of Offering Memorandum. The Company has delivered to each Initial Purchaser, without charge, as many copies of the
Preliminary Offering Memorandum (as amended or supplemented) thereto and documents incorporated by reference therein as such Initial Purchaser reasonably requested, and the Company hereby consents to the use of such copies in the manner

  
 12 

 
contemplated by the Offering Memorandum and this Agreement. The Company will furnish to each Initial Purchaser, without charge, such number of copies of the Final Offering Memorandum thereto and
documents incorporated by reference therein as such Initial Purchaser may reasonably request. 
 (b) Notice and Effect of Material
Events. If at any time prior to the earlier of nine months after the date hereof or the completion of resales of the Notes by the Initial Purchasers, any event shall occur or condition shall exist as a result of which it is necessary, based on
advice of counsel for the Initial Purchasers or for the Company, to amend or supplement the General Disclosure Package or the Final Offering Memorandum in order that the General Disclosure Package or the Final Offering Memorandum, as the case may
be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to a Subsequent
Purchaser, the Company will promptly give the Representatives notice of such event and prepare any amendment or supplement as may be necessary to correct such statement or omission and furnish to the Representatives for review a copy of each such
proposed amendment or supplement; and the Company shall not distribute such proposed amendment or supplement to which the Representatives shall reasonably object. 

(c) Reporting Requirements. Until the completion of the initial resales of the Notes by the Initial Purchasers, the Company will file
all documents required to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and the rules and regulations of the Commission thereunder. The Company has given the Representatives notice of
any filings made pursuant to the Exchange Act or the rules and regulations of the Commission thereunder within 48 hours prior to the Applicable Time; the Company will give the Representatives notice of its intention to make any such filing from the
Applicable Time to the Closing Time and will furnish the Representatives with copies of any such documents a reasonable amount of time prior to such proposed filing, as the case may be, and will not file, except with respect to any document that
counsel has advised the Company is required to be filed under the Exchange Act or the rules and regulations of the Commission thereunder and that does not relate to the Notes, or use any such document to which the Representatives or counsel for the
Initial Purchasers shall reasonably object. 
 (d) Foreign Securities Law Qualifications. Subject to Section 6(a)(i), the Company
will use its best efforts, in cooperation with the Initial Purchasers, to qualify the Notes for offering and sale under the applicable securities laws of such foreign jurisdictions as the Representatives may reasonably request and to maintain such
qualifications in effect so long as required to complete the distribution of the Notes; provided, however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a
dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject. 

(e) Use of Proceeds. The Company will use the net proceeds received by it from the sale of the Notes in the manner specified in the
General Disclosure Package and the Final Offering Memorandum under “Use of Proceeds.” 
 (f) DTCC. The Company will
cooperate with the Initial Purchasers and use its reasonable best efforts to permit the Notes to be eligible for clearance and settlement through the facilities of The Depository Trust & Clearing Corporation (“DTCC”). 

(g) Future Reports to the Representatives. During the period of five years after the Closing Time, the Company will furnish to the
Representatives, (i) as soon as practicable after the end of each fiscal year, copies of the annual report of the Company containing the balance sheet of the Company as of the close of such fiscal year and statements of income,
stockholders’ equity and cash flows for the year 

  
 13 

 
then ended and the opinion thereon of the Company’s independent public or certified public accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy
statement, Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as soon as available, copies of any report or
communication of the Company mailed generally to holders of its capital stock; provided that if any of the foregoing documents are filed or furnished on EDGAR or posted on its website, the requirements of this paragraph will be deemed to be
satisfied by the Company notifying the Representatives of such filing, furnishing or posting, as the case may be. 
 (h) Investment
Limitation. The Company shall not invest or otherwise use the proceeds received by the Company from its sale of the Notes in such a manner as would require the Company or any of its subsidiaries to register as an investment company under the
Investment Company Act. 
 (i) No Manipulation of Price. The Company will not take, directly or indirectly, any action designed to
cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the Company. 

(j) Listing. The Company will use its reasonable best efforts to effect and maintain the listing of the Conversion Shares on the Nasdaq
Global Select Market. 
 (k) Restriction on Sale of Notes. During a period of 60 days from the date of the Final Offering Memorandum,
the Company will not, without the prior written consent of the Representatives, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or file any registration statement under the Securities Act with
respect to any of the foregoing or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any such swap
or transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the Notes and the Conversion Shares to be
sold hereunder, (B) any shares of Common Stock issued by the Company upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof and referred to in the General Disclosure Package and the Final
Offering Memorandum, (C) any shares of Common Stock issued or options to purchase Common Stock granted pursuant to existing employee benefit plans of the Company referred to in the General Disclosure Package and the Final Offering Memorandum,
(D) any shares of Common Stock issued pursuant to any non-employee director stock plan or dividend reinvestment plan referred to in the General Disclosure Package and the Final Offering Memorandum, or (E) up to an aggregate of
3.0 million shares of Common Stock in connection with any acquisition of businesses made by the Company. 
 (l) General
Solicitation. The Company will not make, prepare, use, authorize, approve or distribute any General Solicitation other than those General Solicitations that are set forth on Schedule C hereto. 

SECTION 4. Payment of Expenses. 

(a) Expenses. The Company will pay or cause to be paid all expenses incident to the performance of their obligations under this
Agreement, including (i) preparation, issuance and delivery of the Notes to the Initial Purchasers and the Conversion Shares issuable upon conversion thereof and any charges of DTCC in connection therewith, (ii) the fees and disbursements
of the Company’s counsel, accountants and other advisors, (iii) the qualification of the Notes under foreign securities laws in 

  
 14 

 
accordance with the provisions of Section 3(d) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Initial Purchasers in connection therewith and in
connection with the preparation of the survey of applicable foreign securities laws and any supplement thereto (including, in an amount not to exceed $10,000, the preparation of any Canadian wrapper by special Canadian counsel for the Initial
Purchasers), (iv) the preparation, printing and delivery to the Initial Purchasers of copies of each Preliminary Offering Memorandum, any Issuer Written Information, the Final Term Sheet and the Final Offering Memorandum and any amendments or
supplements thereto and any costs associated with electronic delivery of any of the foregoing by the Initial Purchasers to investors, (v) all fees and expenses of the Trustee and any expenses of any transfer agent or registrar for the Notes or
the Conversion Shares, (vi) the costs and expenses of the Company relating to investor presentations on any “road show” undertaken in connection with the marketing of the Notes, including without limitation, expenses associated with
the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations, travel and lodging expenses of the representatives and officers of the Company and any such consultants,
and the cost of aircraft and other transportation chartered in connection with the road show and (vii) the fees and expenses incurred in connection with the listing of the Common Stock issuable upon conversion of the Notes on the Nasdaq Global
Select Market. 
 (b) Termination of Agreement. If this Agreement is terminated by the Representatives in accordance with the
provisions of Section 5 or Section 10(a)(i) or (iii) hereof, the Company shall reimburse the Initial Purchasers for all of their reasonable, documented,
out-of-pocket expenses including the reasonable fees and disbursements of counsel for the Initial Purchasers. 

SECTION 5. Conditions of the Obligations of the Initial Purchasers. The obligations of the several Initial Purchasers hereunder are
subject to the accuracy of the representations and warranties of the Company contained herein or in certificates of any officer of the Company or any of its subsidiaries, to the performance by the Company of its covenants and other obligations
hereunder, and to the following further conditions: 
 (a) Opinion of Counsel for Company. At the Closing Time, the Representatives
shall have received (i) the favorable opinion, dated the Closing Time, of Stinson Leonard Street LLP, counsel for the Company, to the effect set forth in Exhibit A-1 hereto, (ii) the favorable opinion, dated the Closing Time, of Hogan
Lovells US LLP, special counsel for the Company, to the effect set forth in Exhibit A-2 hereto and (iii) the favorable opinion, dated the Closing Time, of the General Counsel of the Company, to the effect set forth in Exhibit A-3 hereto, in
each case in form and substance reasonably satisfactory to counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of the other Initial Purchasers and to such further effect as counsel to the Initial
Purchasers may reasonably request. In giving such opinions such counsel or the General Counsel may rely upon the opinions of counsel reasonably satisfactory to counsel for the Initial Purchasers. Such counsel or the General Counsel may also state
that, insofar as such opinion involves factual matters, they have relied, to the extent they deem proper, upon certificates of officers and other representatives of the Company and its subsidiaries and certificates of public officials. 

(b) Opinion of Counsel for Initial Purchasers. At the Closing Time, the Representatives shall have received the favorable opinion, dated
the Closing Time, of Davis Polk & Wardwell LLP, counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of the other Initial Purchasers in form and substance reasonably satisfactory to the
Representatives. In giving such opinion such counsel may rely, as to all matters governed by the laws of jurisdictions other than the law of the State of New York, the General Corporation Law of the State of Delaware and the federal securities laws
of the United States, upon the opinions of counsel reasonably satisfactory to the Representatives. Such counsel may also state that, insofar as such opinion involves factual matters, they have relied, to the extent they deem proper, upon
certificates of officers and other representatives of the Company and its subsidiaries and certificates of public officials. 

  
 15 

 (c) Officers’ Certificate. At the Closing Time, there shall not have been, since the
date hereof or since the respective dates as of which information is given in the General Disclosure Package or the Final Offering Memorandum, a Material Adverse Change, and the Representatives shall have received a certificate of the Chief
Executive Officer or the President of the Company and of the Chief Financial or Chief Accounting Officer of the Company, dated the Closing Time, to the effect that (i) there has been no such Material Adverse Change, (ii) the
representations and warranties of the Company in this Agreement are true and correct with the same force and effect as though expressly made at and as of the Closing Time and (iii) the Company has complied with all agreements and satisfied all
conditions on its part to be performed or satisfied at or prior to the Closing Time. 
 (d) Accountant’s Comfort Letter. At the
time of the execution of this Agreement, the Representatives shall have received from KPMG LLP a letter, dated such date, in form and substance reasonably satisfactory to the Representatives, together with signed or reproduced copies of such letter
for each of the other Initial Purchasers containing statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial
information contained in the Offering Memorandum. 
 (e) Bring-down Comfort Letter. At the Closing Time, the Representatives shall
have received from KPMG LLP a letter, dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (d) of this Section, except that the specified date referred to shall be a
date not more than three business days prior to the Closing Time. 
 (f) Lock-up Agreements. On or prior to the date hereof, the
Company shall have furnished to the Representatives an agreement in the form of Exhibit B hereto from each of the executive officers and directors of the Company, and each such agreement shall be in full force and effect at the Closing Time and on
any Delivery Date. 
 (g) Approval of Listing. At the Closing Time, the Conversion Shares shall have been approved for listing on the
Nasdaq Global Select Market, subject only to official notice of issuance. 
 (h) Maintenance of Rating. Since the execution of this
Agreement, there shall not have been any decrease in or withdrawal of the rating of any securities of the Company or any of its subsidiaries by any “nationally recognized statistical rating organization” (as defined in
Section 3(a)(62) of the Exchange Act) or any notice given of any intended or potential decrease in or withdrawal of any such rating or of a possible change in any such rating that does not indicate the direction of the possible change. 

(i) Conditions to Purchase of Optional Notes. In the event that the Initial Purchasers exercise their option provided in
Section 2(b) hereof to purchase all or any portion of the Optional Notes, the representations and warranties of the Company contained herein and the statements in any certificates furnished by the Company and any of its subsidiaries hereunder
shall be true and correct as of each Date of Delivery and, at the relevant Date of Delivery, the Representatives shall have received: 

(i) Opinion of Counsel for Company. If requested by the Representatives, the favorable opinion of Stinson Leonard Street
LLP, counsel for the Company, and Hogan Lovells US LLP, special counsel for the Company, and the General Counsel of the Company, in each case in form and substance reasonably satisfactory to counsel for the Initial Purchasers, dated such Date of
Delivery, relating to the Optional Notes to be purchased on such Date of Delivery and otherwise to the same effect as the opinion required by Section 5(a) hereof. 

  
 16 

 (ii) Opinion of Counsel for Initial Purchasers. If requested by the
Representatives, the favorable opinion of Davis Polk & Wardwell LLP, counsel for the Initial Purchasers, dated such Date of Delivery, relating to the Optional Notes to be purchased on such Date of Delivery and otherwise to the same effect
as the opinion required by Section 5(b) hereof. 
 (iii) Officers’ Certificate. A certificate, dated such
Date of Delivery, of the President or a Vice President of the Company and of the chief financial or chief accounting officer of the Company confirming that the certificate delivered at the Closing Time pursuant to Section 5(c) hereof remains
true and correct as of such Date of Delivery. 
 (iv) Bring-down Comfort Letter. If requested by the Representatives,
a letter from KPMG LLP, in form and substance reasonably satisfactory to the Representatives and dated such Date of Delivery, substantially in the same form and substance as the letter furnished to the Representatives pursuant to Section 5(d)
hereof, except that the “specified date” in the letter furnished pursuant to this paragraph shall be a date not more than three business days prior to such Date of Delivery. 

(j) Additional Documents. At the Closing Time and at each Date of Delivery (if any), counsel for the Initial Purchasers shall have been
furnished with such documents and opinions as they may reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Notes as herein contemplated, or in order to evidence the accuracy of any of the representations or
warranties, or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Notes as herein contemplated shall be reasonably satisfactory in form and substance
to the Representatives and counsel for the Initial Purchasers. 
 (k) Termination of Agreement. If any condition specified in this
Section shall not have been fulfilled when and as required to be fulfilled, this Agreement, or, in the case of any condition to the purchase of Optional Notes on a Date of Delivery which is after the Closing Time, the obligations of the several
Initial Purchasers to purchase the relevant Optional Notes, may be terminated by the Representatives by notice to the Company at any time at or prior to Closing Time or such Date of Delivery, as the case may be, and such termination shall be without
liability of any party to any other party except as provided in Section 4 and except that Sections 1, 7, 8, 9, 14, 15, 16 and 17 shall survive any such termination and remain in full force and effect. 

SECTION 6. Subsequent Offers and Resales of the Notes. 

(a) Offer and Sale Procedures. Each of the Initial Purchasers and the Company hereby establish and agree to observe the following
procedures in connection with the offer and sale of the Notes: 
 (i) Offers and Sales. Offers and sales of the Notes
shall be made to such persons and in such manner as is contemplated by the Offering Memorandum. Each Initial Purchaser severally agrees that it will not offer, sell or deliver any of the Notes in any jurisdiction outside the United States except
under circumstances that will result in compliance with the applicable laws thereof, and that it will take at its own expense whatever action is required to permit its purchase and resale of the Notes in such jurisdictions. The Company has not
entered into any contractual arrangement, other than this Agreement, with respect to the distribution of the Notes or the Common Stock issuable upon conversion of the Notes and the Company will not enter into any such arrangement except as
contemplated thereby. 
 (ii) No Public Offering. The Notes will not be offered or sold in any manner involving a
public offering within the meaning of Section 4(a)(2) of the Securities Act. 

  
 17 

 (iii) Legends. Each of the Notes will bear, to the extent applicable, the
legend contained in “Notice to Investors” in the General Disclosure Package and the Final Offering Memorandum for the time period and upon the other terms stated therein. 

(iii) Minimum Principal Amount. No sale of the Notes to any one Subsequent Purchaser will be for less than U.S. $1,000
principal amount and no Security will be issued in a smaller principal amount. If the Subsequent Purchaser is a non-bank fiduciary acting on behalf of others, each person for whom it is acting must purchase at least U.S. $1,000 principal amount of
the Notes. 
 (b) Covenants of the Company. The Company covenants with each Initial Purchaser as follows: 

(i) Integration. The Company agrees that it will not and will cause its Affiliates not to, directly or indirectly,
solicit any offer to buy, sell or make any offer or sale of, or otherwise negotiate in respect of, securities of the Company of any class if, as a result of the doctrine of “integration” referred to in Rule 502 under the Securities
Act Regulations, such offer or sale would render invalid (for the purpose of (i) the sale of the offered Notes by the Company to the Initial Purchasers, (ii) the resale of the offered Notes by the Initial Purchasers to Subsequent
Purchasers or (iii) the resale of the offered Notes by such Subsequent Purchasers to others) the exemption from the registration requirements of the Securities Act provided by, in the case of sales of Notes to the Initial Purchasers,
Section 4(a)(2) thereof or, in the case of resales by the Initial Purchasers or Subsequent Purchasers, by Rule 144A. 

(ii) Rule 144A Information. The Company agrees that, in order to render the offered Notes eligible for resale pursuant
to Rule 144A, while any of the offered Notes remain outstanding, it will make available, upon request, to any holder of offered Notes or prospective purchasers of Notes the information specified in Rule 144A(d)(4), unless the Company
furnishes information to the Commission pursuant to Section 13 or 15(d) of the Exchange Act. 
 (iii) Restriction on
Repurchases. Until the expiration of one year after the original issuance of the offered Notes, the Company will not, and will cause its Affiliates not to, resell any offered Notes which are “restricted securities” (as such term is
defined under Rule 144(a)(3)), whether as beneficial owner or otherwise (except as agent acting as a securities broker on behalf of and for the account of customers in the ordinary course of business in unsolicited broker’s transactions).

 (c) Representations, Warranties and Agreements of the Initial Purchasers. Each Initial Purchaser severally and not jointly
represents and warrants to, and agrees with, the Company that it is a Qualified Institutional Buyer and an “accredited investor” within the meaning of Rule 501(a) under the Securities Act Regulations. Each Initial Purchaser
understands that the Notes have not been and will not be registered under the Securities Act and may not be sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the
Securities Act. Each Initial Purchaser severally represents and agrees that it has not sold, and will not sell, any Notes constituting part of its allotment except in accordance with Rule 144A. Each Initial Purchaser severally represents and agrees
that neither it nor any person acting on its behalf has made or will make offers or sales of the Notes in any manner involving a public offering in the United States within the meaning of Section 4(a)(2) of the Securities Act. Each Initial
Purchaser will take reasonable steps to inform, and cause each of its affiliates (as such term is defined in Rule 501(b) under the Securities Act Regulations (each, an “Affiliate”)) to take reasonable steps to inform, persons acquiring
Notes from such Initial Purchaser or Affiliate, as the case may be, in the United States that the Notes (A) have not been and will not be registered under the Securities Act, (B) are being sold to them without registration under the

  
 18 

 
Securities Act in reliance on Rule 144A and (C) may not be sold or otherwise transferred except (1) to the Company or one of its subsidiaries, (2) under a registration
statement that has been declared effective under the Securities Act, (3) to a person whom the seller reasonably believes is a Qualified Institutional Buyer that is purchasing such Securities for its own account or for the account of a Qualified
Institutional Buyer to whom notice is given that the offer, sale or transfer is being made in reliance on Rule 144A, all in compliance with Rule 144A, or (4) pursuant to the exemption from registration provided by Rule 144 under the
Securities Act (if available). 
 SECTION 7. Indemnification. 

(a) Indemnification of Initial Purchasers. The Company agrees to indemnify and hold harmless each Initial Purchaser, its Affiliates, its
officers, employees, selling agents and each person, if any, who controls any Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows: 

(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement
or alleged untrue statement of a material fact included in any Preliminary Offering Memorandum, the Final Offering Memorandum, the information contained in the Final Term Sheet, any Issuer Written Information or any other information used by or on
behalf of the Company in connection with the offer or sale of the Notes (or any amendment or supplement to the foregoing) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; 
 (ii) against any and all loss, liability, claim,
damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based
upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 7(d) below) any such settlement is effected with the written consent of the Company; 

(iii) against any and all expense whatsoever, as incurred (including the reasonable fees and disbursements of counsel chosen by
the Representatives), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such
untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above; 

provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue
statement or omission or alleged untrue statement or omission made in any Preliminary Offering Memorandum or the Final Offering Memorandum (or any amendment or supplement to the foregoing) in reliance upon and in conformity with the Initial
Purchaser Information. 
 (b) Indemnification of Company, Directors, Officers and Employees. Each Initial Purchaser severally agrees
to indemnify and hold harmless the Company, its directors, its officers, its employees and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any
and all loss, liability, claim, damage and expense described in the indemnity contained in subsection (a) of this Section, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in
any Preliminary Offering Memorandum or the Final Offering Memorandum (or any amendment or supplement to the foregoing) in reliance upon and in conformity with the Initial Purchaser Information. 

  
 19 

 (c) Actions against Parties; Notification. Each indemnified party shall give notice as
promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any
liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. In case any such action is
brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in, and, to the extent that it shall elect, jointly with all other
indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably satisfactory to such
indemnified party; provided, however, if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that a conflict may arise between the positions of the
indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the
indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such indemnified party or parties. Upon
receipt of notice from the indemnifying party to such indemnified party of such indemnifying party’s election so to assume the defense of such action and approval by the indemnified party of counsel, the indemnifying party will not be liable to
such indemnified party under this Section 7 for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless (i) the indemnified party shall have employed separate counsel in
accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel (together with local counsel), approved by the indemnifying party
(the Representatives in the case of Section 7(b) and Section 8), representing the indemnified parties who are parties to such action) or (ii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party
to represent the indemnified party within a reasonable time after notice of commencement of the action, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party. No indemnifying party shall, without
the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any
claim whatsoever in respect of which indemnification or contribution could be sought under this Section 7 or Section 8 hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement,
compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of
fault, culpability or a failure to act by or on behalf of any indemnified party. 
 (d) Settlement without Consent if Failure to
Reimburse. If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement
of the nature contemplated by Section 7(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying
party shall have received notice of the terms of such settlement at least 45 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request
prior to the date of such settlement. 

  
 20 

 SECTION 8. Contribution. If the indemnification provided for in Section 7 hereof is
for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such
losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Initial Purchasers,
on the other hand, from the offering of the Notes pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and of the Initial Purchasers, on the other hand, in connection with the statements or omissions which resulted in such losses, liabilities,
claims, damages or expenses, as well as any other relevant equitable considerations. 
 The relative benefits received by the Company, on
the one hand, and the Initial Purchasers, on the other hand, in connection with the offering of the Notes pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Notes
pursuant to this Agreement (before deducting expenses) received by the Company, on the one hand, and the total discounts and commissions received by the Initial Purchasers, on the other hand, bear to the aggregate initial offering price of the Notes
as set forth on the cover of the Final Offering Memorandum. 
 The relative fault of the Company, on the one hand, and the Initial
Purchasers, on the other hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied
by the Company or by the Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

The Company and the Initial Purchasers agree that it would not be just and equitable if contribution pursuant to this Section 8 were
determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 8.
The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 8 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or
omission or alleged omission. 
 Notwithstanding the provisions of this Section 8, no Initial Purchaser shall be required to contribute
any amount in excess of the amount by which the total price at which the Notes purchased by it and distributed to the public were offered to the public exceeds the amount of any damages that such Initial Purchaser has otherwise been required to pay
by reason of any such untrue or alleged untrue statement or omission or alleged omission. 
 No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 

For purposes of this Section 8, each officer of an Initial Purchaser, each employee of an Initial Purchaser and each person, if any, who
controls an Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and each Initial Purchaser’s Affiliates and selling agents shall have the same rights to contribution as such
Initial Purchaser, and each director of the Company, each officer of the Company, each employee of the Company and each person, if any, who 

  
 21 

 
controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as the Company. The Initial
Purchasers’ respective obligations to contribute pursuant to this Section 8 are several in proportion to the aggregate principal amount of Firm Notes set forth opposite their respective names in Schedule A hereto and not joint. 

SECTION 9. Representations, Warranties and Agreements to Survive. All representations, warranties and agreements contained in this
Agreement or in certificates of officers of the Company or any of its subsidiaries submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any Initial Purchaser
or its Affiliates or selling agents, any person controlling any Initial Purchaser, its officers or directors or any person controlling the Company and (ii) delivery of and payment for the Notes. 

SECTION 10. Termination of Agreement. 

(a) Termination. The Representatives may terminate this Agreement, by notice to the Company, at any time at or prior to the Closing Time
(i) if there has been, in the judgment of the Representatives, since the time of execution of this Agreement or since the respective dates as of which information is given in the General Disclosure Package or the Final Offering Memorandum, any
Material Adverse Change, or (ii) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or
crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Representatives,
impracticable or inadvisable to proceed with the completion of the offering or to enforce contracts for the sale of the Notes, or (iii) if trading in any securities of the Company has been suspended or materially limited by the Commission or
the Nasdaq Global Select Market, or (iv) if trading generally on the New York Stock Exchange or in the Nasdaq Global Market has been suspended or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges
for prices have been required, by any of said exchanges or by order of the Commission, FINRA or any other governmental authority, or (v) a material disruption has occurred in commercial banking or securities settlement or clearance services in
the United States, or (vi) if a banking moratorium has been declared by either Federal or New York authorities. 
 (b)
Liabilities. If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other party except as provided in Section 4 hereof, and provided further that Sections 1, 7, 8, 9, 14,
15, 16 and 17 shall survive such termination and remain in full force and effect. 
 SECTION 11. Default by One or More of the Initial
Purchasers. If one or more of the Initial Purchasers shall fail at the Closing Time or a Date of Delivery to purchase the Notes which it or they are obligated to purchase under this Agreement (the “Defaulted Securities”), the
Representatives shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Initial Purchasers, or any other initial purchasers, to purchase all, but not
less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representatives shall not have completed such arrangements within such
24-hour period, then: 
 (i) if the number of Defaulted Securities does not exceed
10% of the aggregate principal amount of the Notes to be purchased on such date, each of the non-defaulting Initial Purchasers shall be obligated, severally and not jointly, to purchase the full amount thereof
in the proportions that their respective purchase obligations hereunder bear to the purchase obligations of all non-defaulting Initial Purchasers, or 

  
 22 

 (ii) if the number of Defaulted Securities exceeds 10% of the aggregate principal
amount of the Notes to be purchased on such date, this Agreement or, with respect to any Date of Delivery which occurs after the Closing Time, the obligation of the Initial Purchasers to purchase, and the Company to sell, the Optional Notes to be
purchased and sold on such Date of Delivery, shall terminate without liability on the part of any non-defaulting Initial Purchaser. 

No action taken pursuant to this Section shall relieve any defaulting Initial Purchaser from liability in respect of its default. 

In the event of any such default which does not result in a termination of this Agreement or, in the case of a Date of Delivery which is after
the Closing Time, which does not result in a termination of the obligation of the Initial Purchasers to purchase and the Company to sell the relevant Optional Notes, as the case may be, either the (i) Representatives or (ii) the Company
shall have the right to postpone Closing Time or the relevant Date of Delivery, as the case may be, for a period not exceeding seven days in order to effect any required changes in the General Disclosure Package or the Final Offering Memorandum or
in any other documents or arrangements. As used herein, the term “Initial Purchaser” includes any person substituted for an Initial Purchaser under this Section 11. 

SECTION 12. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if
mailed or transmitted by any standard form of telecommunication. Notices to the Initial Purchasers shall be directed as follows: 
 If to the
Representatives: 
 Merrill Lynch, Pierce, Fenner & Smith 

                    Incorporated 

One Bryant Park 
 New York, New
York 10036 
 Attention: Syndicate Department (facsimile: (646) 855-3073) 

With a copy to: ECM Legal (facsimile: (212) 230-8730) 

Wells Fargo Securities, LLC 

375 Park Avenue 
 New York, New
York 10152 
 Attention: Syndicate 

with a copy to: 
 Davis
Polk & Wardwell 
 450 Lexington Avenue 

New York, New York 10017 

Facsimile: (212) 450-4111 

Attention: Michael Kaplan, Esq. 

If to the Company: 
 Euronet
Worldwide, Inc. 
 4601 College Boulevard 

Leawood, Kansas 66211 
 Facsimile:
(913) 327-1921 
 Attention: General Counsel 

  
 23 

 with a copy to: 

Stinson Leonard Street LLP 
 1201
Walnut Street 
 Suite 2900 

Kansas City, Kansas 64106 

Facsimile: (816) 691-3495 

Attention: John Granda, Esq. 

Hogan Lovells US LLP 
 Columbia
Square 
 555 Thirteenth Street, NW 

Washington, DC 20004 
 Facsimile:
(202) 637-5910 
 Attention: Eve N. Howard, Esq. 

SECTION 13. No Advisory or Fiduciary Relationship. The Company acknowledges and agrees that (a) the purchase and sale of the Notes
pursuant to this Agreement, including the determination of the initial offering price of the Notes and any related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and the several
Initial Purchasers, on the other hand, (b) in connection with the offering of the Notes and the process leading thereto, each Initial Purchaser is and has been acting solely as a principal and is not the agent or fiduciary of the Company, any
of its subsidiaries or their respective stockholders, creditors, employees or any other party, (c) no Initial Purchaser has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering of
the Notes or the process leading thereto (irrespective of whether such Initial Purchaser has advised or is currently advising the Company or any of its subsidiaries on other matters) and no Initial Purchaser has any obligation to the Company with
respect to the offering of the Notes except the obligations expressly set forth in this Agreement, (d) the Initial Purchasers and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ
from those of the Company and (e) the Initial Purchasers have not provided any legal, accounting, regulatory or tax advice with respect to the offering of the Notes and the Company has consulted its own respective legal, accounting, regulatory
and tax advisors to the extent it deemed appropriate. 
 SECTION 14. Parties. This Agreement shall each inure to the benefit of and
be binding upon the Initial Purchasers and the Company and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than the Initial Purchasers and
the Company and their respective successors and the controlling persons and officers, employees and directors referred to in Sections 7 and 8 and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Initial Purchasers and the Company and their respective successors, and
said controlling persons and officers, employees and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Securities from any Initial Purchaser shall be deemed to be a
successor by reason merely of such purchase. 
 SECTION 15. Trial by Jury. The Company (on its behalf and, to the extent permitted by
applicable law, on behalf of its stockholders and affiliates) and each of the Initial Purchasers hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of
or relating to this Agreement or the transactions contemplated hereby. 
 SECTION 16. GOVERNING LAW. THIS AGREEMENT AND ANY CLAIM,
CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF, THE STATE OF NEW YORK WITHOUT REGARD TO ITS CHOICE OF LAW PROVISIONS. 

  
 24 

 SECTION 17. Consent to Jurisdiction; Waiver of Immunity. Any legal suit, action or
proceeding arising out of or based upon this Agreement or the transactions contemplated hereby (“Related Proceedings”) shall be instituted in (i) the federal courts of the United States of America located in the City and County
of New York, Borough of Manhattan or (ii) the courts of the State of New York located in the City and County of New York, Borough of Manhattan (collectively, the “Specified Courts”), and each party irrevocably submits to the exclusive
jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court, as to which such jurisdiction is non-exclusive) of the Specified Courts in any Related Proceedings. Service of any process, summons, notice
or document by mail to such party’s address set forth above shall be effective service of process for any Related Proceeding brought in any Specified Court. The parties irrevocably and unconditionally waive any objection to the laying of venue
of any Related Proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any Specified Court that any Related Proceeding brought in any such court has been brought in an inconvenient forum. 

SECTION 18. TIME. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO
NEW YORK CITY TIME. 
 SECTION 19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be
deemed to be an original, but all such counterparts shall together constitute one and the same Agreement. 
 SECTION 20. Effect of
Headings. The Section headings herein are for convenience only and shall not affect the construction hereof. 

  
 25 

 If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement among the Initial Purchasers and the Company in accordance with its terms. 

 

							
		 	Very truly yours,
		
		 	 EURONET WORLDWIDE, INC.

			
		 	By	 	/s/ Rick L. Weller
		 		 	  

		 		 	Name:	 	Rick L. Weller
		 		 	Title:	 	Executive Vice President and
		 		 		 	Chief Financial Officer

  

					
	CONFIRMED AND ACCEPTED,
        as of the date first above written:	  	
		
	 MERRILL LYNCH, PIERCE, FENNER & SMITH

INCORPORATED
	  	
			
	 By:
	 	 MERRILL LYNCH, PIERCE, FENNER & SMITH

INCORPORATED
	  	
			
	 By
	 	/s/ Iam Simmonds	  	
		 	  
	  	
		 	 Authorized Signatory
	  	
		
	 WELLS FARGO SECURITIES, LLC
	  	
			
	 By:
	 	 WELLS FARGO SECURITIES, LLC
	  	
			
	 By
	 	/s/ David Herman	  	
		 	  
	  	
		 	 Authorized Signatory
	  	

 For themselves and as Representatives of the other Initial Purchasers named in Schedule A hereto. 

  
 26 

 SCHEDULE A 

The initial offering price of the Notes shall be 100% of the principal amount thereof, plus accrued interest, if any, from the date of issuance. 

The purchase price to be paid by the Initial Purchasers for the Notes shall be 97.4503% of the principal amount thereof. 

The interest rate on the Notes shall be 1.50% per annum. 
  

					
	Name of Initial Purchaser	  	Principal
Amount of
Securities	 
	 Merrill Lynch, Pierce, Fenner & Smith

                   
 Incorporated
	  	$	154,430,000	  
	 Wells Fargo Securities, LLC
	  	$	154,430,000	  
	 BMO Capital Markets Corp.
	  	$	34,317,000	  
	 U.S. Bancorp Investments, Inc.
	  	$	6,823,000	  
	 Total
	  	$	350,000,000	  
		  	  
	  
	 

  

  
 Sch A-1 

 SCHEDULE B 

Final Term Sheet 
  

			
	PRICING TERM SHEET	  	Strictly Confidential
	Dated as of October 30, 2014	  	

  
 

 
 Euronet Worldwide, Inc. 

1.50% Convertible Senior Notes due 2044 

The information in this pricing term sheet relates to Euronet Worldwide, Inc.’s offering (the “Offering”) of its 1.50% Convertible Senior
Notes due 2044 (the “Notes”) and should be read together with the preliminary offering memorandum dated October 30, 2014 (including the documents incorporated by reference therein) relating to the Offering (the “Preliminary
Offering Memorandum”). The information in this pricing term sheet supersedes the information in the Preliminary Offering Memorandum to the extent that it is inconsistent therewith. In all other respects, this pricing term sheet is qualified in
its entirety by reference to the Preliminary Offering Memorandum. Terms used but not defined herein have the meanings ascribed to them in the Preliminary Offering Memorandum. 

 

			
		
	Issuer:	  	Euronet Worldwide, Inc. (NASDAQ: EEFT)
		
	Securities Offered:	  	1.50% Convertible Senior Notes due 2044
		
	Offering Size:	  	$350,000,000 aggregate principal amount (or $402,500,000 aggregate principal amount if the initial purchasers exercise their option to purchase additional Notes in full)
		
	Issue Price:	  	100% of the principal amount, plus accrued interest, if any, from the Settlement Date
		
	Use of Proceeds:	  	 The Issuer estimates that the proceeds from the Offering will be approximately $340.8 million (or $392.0 million if the initial purchasers
exercise their option to purchase additional Notes in full), after deducting fees and estimated expenses.
  

The Issuer expects to use a portion of the net proceeds from the Offering to fund the repurchase of approximately $65 million of its common stock concurrently
with the pricing of the Offering in privately negotiated transactions effected through the initial purchasers or their affiliates as agents of the Issuer at a purchase price per share equal to the closing price per share on the pricing date, which
was $53.47. The Issuer expects to use the remaining net proceeds, including from the potential exercise of the initial purchasers’ option to purchase additional Notes, to repay borrowings outstanding under its revolving credit facility, which
had an outstanding balance of $293.1 million as of October 30, 2014, and any remaining net proceeds for general corporate purposes, which may include additional share repurchases or acquisitions. See “Use of Proceeds” in the Preliminary
Offering Memorandum.

		
	Maturity:	  	October 1, 2044, unless earlier purchased, redeemed or converted
		
	Interest Rate:	  	1.50% per annum payable semiannually in arrears in cash
		
	Interest Payment Dates:	  	April 1 and October 1, beginning April 1, 2015

  
 Sch B - 1 

			
		
	Contingent Interest:	  	Beginning with the six-month interest period commencing on October 1, 2020, the Issuer will pay contingent interest on the Notes during any six-month interest period if the trading price per $1,000 principal amount of the Notes
for each of the five trading days immediately preceding the first day of such six-month period equals or exceeds $1,200. During any six-month interest period in which contingent interest is payable, the contingent interest payable per $1,000
principal amount of Notes will equal the product of (i) 0.50% per annum and (ii) the average trading price of $1,000 principal amount of Notes during the five trading days immediately preceding the first day of the applicable six-month interest
period and will be payable in the same manner, at the same time and upon the same terms as regular interest payable on the Notes. Any contingent interest payable on the Notes will be in addition to the regular interest payable on the
Notes.
		
	Optional Redemption:	  	The Issuer may not redeem the Notes prior to April 5, 2018. The Issuer may redeem for cash all or part of the Notes, at its option, (i) on or after April 1, 2018 if the closing sale price of its common stock has been at least 130%
of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately
preceding the date on which the Issuer provides notice of redemption and (ii) on or after October 5, 2020 and prior to the maturity date, regardless of the foregoing sale price condition. In each case, the redemption price will equal 100% of the
principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes.
		
	Repurchase of Notes on
Certain Dates:	  	Holders of Notes may require the Issuer to repurchase for cash all or any portion of their Notes on each of October 1, 2020, October 1, 2024, October 1, 2029, October 1, 2034 and October 1, 2039 at a repurchase price equal to 100%
of the principal amount of the Notes being repurchased, plus accrued and unpaid interest to, but excluding the relevant repurchase date.
		
	NASDAQ Last Reported
Sale Price on October 30,
2014:	  	$53.47 per share of common stock
		
	Initial Conversion Rate:	  	13.8534 shares of common stock per $1,000 principal amount of Notes
		
	Initial Conversion Price:	  	Approximately $72.18 per share of common stock
		
	Conversion Premium:	  	Approximately 35% above the NASDAQ Last Reported Sale Price on October 30, 2014
		
	Make Whole Premium
Upon Conversion Upon a
Make Whole Adjustment
Event:	  	If certain corporate events as described in the Preliminary Offering Memorandum occur at any time prior to October 5, 2020, which is referred to as a “make whole adjustment event,” the conversion rate for any Notes
converted following such make-whole adjustment event will, in certain circumstances and for a limited period of time, be increased by a number of additional shares of common stock. The number of additional shares will be determined by reference to
the following table and is based on the effective date of such make whole adjustment event and the applicable “stock price” (as defined in the Preliminary Offering Memorandum) per share of common stock for the make whole adjustment
event:

  
 Sch B - 2 

																																																					
	 	  	Stock Price	 
	 Effective Date
	  	$53.47	 	  	$55.00	 	  	$60.00	 	  	$65.00	 	  	$70.00	 	  	$72.18	 	  	$80.00	 	  	$90.00	 	  	$93.84	 	  	$100.00	 	  	$120.00	 	  	$140.00	 	  	$160.00	 
	 November 5, 2014
	  	 	4.8486	  	  	 	4.5509	  	  	 	3.7232	  	  	 	3.0734	  	  	 	2.5579	  	  	 	2.3667	  	  	 	1.8124	  	  	 	1.3206	  	  	 	1.1775	  	  	 	0.9874	  	  	 	0.5925	  	  	 	0.3864	  	  	 	0.2693	  
	 October 1, 2015
	  	 	4.8486	  	  	 	4.3184	  	  	 	3.4738	  	  	 	2.8152	  	  	 	2.2973	  	  	 	2.1068	  	  	 	1.5604	  	  	 	1.0879	  	  	 	0.9539	  	  	 	0.7790	  	  	 	0.4339	  	  	 	0.2692	  	  	 	0.1833	  
	 October 1, 2016
	  	 	4.8486	  	  	 	4.1465	  	  	 	3.2665	  	  	 	2.5831	  	  	 	2.0493	  	  	 	1.8543	  	  	 	1.3015	  	  	 	0.8390	  	  	 	0.7126	  	  	 	0.5529	  	  	 	0.2660	  	  	 	0.1519	  	  	 	0.1013	  
	 October 1, 2017
	  	 	4.8486	  	  	 	4.0720	  	  	 	3.1363	  	  	 	2.4106	  	  	 	1.8426	  	  	 	1.6342	  	  	 	1.0409	  	  	 	0.5463	  	  	 	0.4172	  	  	 	0.2672	  	  	 	0.0800	  	  	 	0.0421	  	  	 	0.0301	  
	 April 5, 2018
	  	 	4.8486	  	  	 	4.0576	  	  	 	3.0908	  	  	 	2.3460	  	  	 	1.7663	  	  	 	1.5539	  	  	 	0.9439	  	  	 	0.4011	  	  	 	0.2403	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  
	 October 1, 2018
	  	 	4.8486	  	  	 	4.0502	  	  	 	3.0412	  	  	 	2.2734	  	  	 	1.6861	  	  	 	1.4744	  	  	 	0.8786	  	  	 	0.3679	  	  	 	0.2198	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  
	 October 1, 2019
	  	 	4.8486	  	  	 	4.0429	  	  	 	2.8783	  	  	 	2.0135	  	  	 	1.3866	  	  	 	1.1730	  	  	 	0.6265	  	  	 	0.2390	  	  	 	0.1406	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  
	 October 5, 2020
	  	 	4.8486	  	  	 	4.3284	  	  	 	2.8133	  	  	 	1.5312	  	  	 	0.4323	  	  	 	0.0009	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  

  

			
		
		  	 The exact stock prices and effective dates may not be set forth in the table above, in which case if the stock price is:

 
 •     between two
stock prices in the table or the effective date is between two effective dates in the table, the number of additional shares will be determined by a straight-line interpolation between the number of additional shares set forth for the next higher
and next lower stock prices and the earlier and later effective dates, as applicable, based on a 365-day year;
  

•     in excess of $160.00 per share (subject to adjustment), no additional shares will
be added to the conversion rate; and
  

•     less than $53.47 per share (subject to adjustment), no additional shares will be
added to the conversion rate.
  
 Notwithstanding the foregoing, in no event will the
conversion rate exceed 18.7020 shares per $1,000 principal amount of Notes, though such number of shares will be adjusted for the same events for which the conversion rate is adjusted as described under “Description of the Notes—Conversion
of Notes—Conversion Rate Adjustments” in the Preliminary Offering Memorandum.

		
	 Trade Date:
	  	October 30, 2014
		
	 Settlement Date:
	  	November 5, 2014
		
	 CUSIP/ISIN:
	  	298736 AG4/ US298736AG45
		
	 Joint Book-Running
Managers:
	  	 Merrill Lynch, Pierce, Fenner & Smith

                    Incorporated

 
 Wells Fargo Securities, LLC

		
	 Co-Managers:
	  	BMO Capital Markets Corp.
		
		  	U.S. Bancorp Investments, Inc.

  
  

This communication is intended for the sole use of the person to whom it is provided by the sender. This material is confidential, is for your information
only and is not intended to be used by anyone other than you. This information does not purport to be a complete description of the Notes or the Offering. 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy the Notes nor shall there be any sale of the Notes in any
state in which such solicitation or sale would be unlawful prior to registration or qualification of the Notes under the laws of any such state. 

Neither the Notes nor any shares of the Issuer’s common stock issuable upon conversion of the Notes have been, or will be, registered under the
Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws, and neither may be offered or sold within the United States or to, or for the account or benefit

  
 Sch B - 3 

 
of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act or any other applicable securities laws.
Accordingly, the Notes are being offered and sold only to “qualified institutional buyers” (as defined in Rule 144A under the Securities Act). The Notes and any shares of the Issuer’s common stock issuable upon conversion of the Notes
are not transferable except in accordance with the restrictions described under “Notice to Investors” and “Transfer Restrictions” in the Preliminary Offering Memorandum. 

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES
WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. 

  
 Sch B - 4 

 SCHEDULE C 

Issuer Written Information 
 Final Term
Sheet in the form set forth on Schedule B 
 General Solicitations 

Launch Press Release dated October 30, 2014 
 Pricing Press
Release dated October 30, 2014 

  
 Sch C - 1 

 SCHEDULE D 

Subsidiaries of the Company 
  

			
	 Subsidiary
	  	 Jurisdiction

	 “Euronet Ukraine” Limited Liability Company
	  	Ukraine
		
	 121 Payments Limited
	  	United Kingdom
		
	 ATX Middle East FZC
	  	United Arab Emirates
		
	 ATX Software Ltd
	  	United Kingdom
		
	 cadooz GmbH
	  	Germany
		
	 cadooz rewards GmbH
	  	Germany
		
	 Cashlink Bangladesh Ltd.
	  	Bangladesh
		
	 Continental Exchange Solutions, Inc.
	  	Delaware
		
	 Continental Payment Solutions, Inc.
	  	California
		
	 Currency Online Limited
	  	New Zealand
		
	 Currency Online Limited
	  	United Kingdom
		
	 Delta Euronet GmbH
	  	Germany
		
	 DFX Limited
	  	New Zealand
		
	 EFT Americas, Inc.
	  	Delaware
		
	 EFT Services Holding B.V.
	  	Netherlands
		
	 EFT-Usluge d.o.o.
	  	Croatia
		
	 EIM (FX) Limited
	  	United Kingdom
		
	 Electronic Transactions Network Ltd.
	  	Bangladesh
		
	 epay (Shanghai) Technology Development Co., Ltd. d.b.a. epay China
	  	China
		
	 epay Australia Holdings Pty Ltd
	  	Australia
		
	 epay Australia Pty Ltd
	  	Australia
		
	 epay Digital Middle East FZ-LLC
	  	United Arab Emirates
		
	 epay Digital SAS
	  	France
		
	 e-pay Holdings Ltd
	  	United Kingdom
		
	 epay Ltd
	  	United Kingdom
		
	 epay New Zealand Limited
	  	New Zealand
		
	 Euronet (London) UK Holdings Limited
	  	United Kingdom
		
	 Euronet 360 Finance Limited
	  	United Kingdom
		
	 Euronet Asia Holdings Limited
	  	Hong Kong
		
	 Euronet Banktechnikai Szolgaltato Kft.
	  	Hungary
		
	 Euronet Bulgaria EOOD
	  	Bulgaria
		
	 Euronet Business Holdings, S.L.U.
	  	Spain
		
	 Euronet Card Services S.A.
	  	Greece
		
	 Euronet Elektronik İşlem Hizmetleri Limited Şirketi
	  	Turkey
		
	 Euronet ETT (China) Co. Ltd.
	  	China

  
 D-1 

			
	 Subsidiary
	  	 Jurisdiction

	 Euronet Middle East W.L.L.
	  	Bahrain
		
	 Euronet Middle East, Africa & Pakistan LLC
	  	Egypt
		
	 Euronet Movilcarga S.L.
	  	Spain
		
	 Euronet Pakistan (Pvt.) Limited
	  	Pakistan
		
	 Euronet Pakistan Holdings Inc.
	  	Delaware
		
	 Euronet Pay & Transaction Services S.R.L.
	  	Italy
		
	 Euronet Payment Services Ltd
	  	United Kingdom
		
	 Euronet Polska Spółka z o.o.
	  	Poland
		
	 Euronet Prepaid Hellas Ltd.
	  	Greece
		
	 Euronet Services d.o.o.
	  	Serbia
		
	 Euronet Services India Pvt. Ltd.
	  	India
		
	 Euronet Services Kft.
	  	Hungary
		
	 Euronet Services Malaysia Sdn. Bhd.
	  	Malaysia
		
	 Euronet Services O.O.O.
	  	Russia
		
	 Euronet Services S.R.L.
	  	Romania
		
	 Euronet Services Schweiz GmbH
	  	Switzerland
		
	 Euronet Services Slovakia, spol. s r.o.
	  	Slovak Republic
		
	 Euronet Services, Spol. s r.o.
	  	Czech Republic
		
	 Euronet Software UK Ltd
	  	United Kingdom
		
	 Euronet Telerecarga, S.L.U.
	  	Spain
		
	 Euronet USA, LLC
	  	Arkansas
		
	 EWI Foreign Holdings Limited
	  	Cyprus
		
	 Gescoro Inc.
	  	Canada
		
	 HiFM Limited
	  	United Kingdom
		
	 HiFX Australia Pty Ltd
	  	Australia
		
	 HiFX Developments Limited
	  	United Kingdom
		
	 HiFX Europe Ltd
	  	United Kingdom
		
	 HiFX Foreign Exchange Limited
	  	United Kingdom
		
	 HiFX Insurance Services Limited
	  	United Kingdom
		
	 HiFX Limited
	  	New Zealand
		
	 HiFX Mortgage Services Limited
	  	United Kingdom
		
	 HiFX Products Limited
	  	United Kingdom
		
	 HiFX, Inc.
	  	Delaware
		
	 Jiayintong (Beijing) Technology Development Co. Ltd. d.b.a. Euronet China
	  	China
		
	 Omega Logic Ltd
	  	United Kingdom
		
	 PaySpot, Inc.
	  	Delaware
		
	 PFX Pty Ltd
	  	Australia
		
	 PT G4S Euronet Nusantara
	  	Indonesia

  
 D-2 

			
	 Subsidiary
	  	 Jurisdiction

	 Pure Commerce (S) Pte. Ltd.
	  	Singapore
		
	 Pure Commerce Japan Pty Ltd
	  	Australia
		
	 Pure Commerce Korea YH
	  	Korea
		
	 Pure Commerce Pty Limited
	  	Australia
		
	 Pure Commerce Shared Service Pte. Ltd.
	  	Singapore
		
	 Pure Processing Pte. Ltd.
	  	Singapore
		
	 Pure-Commerce Ltd
	  	Isle of Man
		
	 Ria Chile Servicios Financieros SpA
	  	Chile
		
	 RIA de Centroamérica, S.A. de C.V.
	  	El Salvador
		
	 RIA de la Hispaniola, C.porA
	  	Dominican Republic
		
	 RIA Deutschland GmbH
	  	Germany
		
	 RIA Envia Financial Services Belgium SPRL
	  	Belgium
		
	 RIA Envia Financial Services GmbH
	  	Germany
		
	 RIA Envia, Inc.
	  	Delaware
		
	 RIA Financial Services AG
	  	Switzerland
		
	 RIA Financial Services Australia Pty. Ltd.
	  	Australia
		
	 RIA Financial Services Ireland Limited
	  	Ireland
		
	 RIA Financial Services Ltd
	  	United Kingdom
		
	 RIA Financial Services Netherlands B.V.
	  	Netherlands
		
	 RIA Financial Services New Zealand Limited
	  	New Zealand
		
	 RIA Financial Services Norway AS
	  	Norway
		
	 RIA Financial Services Puerto Rico, Inc.
	  	Puerto Rico
		
	 RIA Financial Services Sweden AB
	  	Sweden
		
	 RIA Financial Services, Denmark ApS
	  	Denmark
		
	 RIA France SAS
	  	France
		
	 RIA Italia S.R.L.
	  	Italy
		
	 RIA Money Transfer Services Pvt. Ltd.
	  	India
		
	 Ria Money Transfer, S.A. de C.V.
	  	Mexico
		
	 RIA Netherlands Holding B.V.
	  	Netherlands
		
	 RIA Payment Institution EP, S.A.U.
	  	Spain
		
	 RIA Spain Holdings S.L.U.
	  	Spain
		
	 RIA Telecommunications of Canada Inc.
	  	Canada
		
	 RIA Telecommunications of New York, Inc.
	  	New York
		
	 Smart PayNetWork SA
	  	Romania
		
	 TBK (FM) Limited
	  	United Kingdom
		
	 Telecom Net S.A. Logistica Digital
	  	Brazil
		
	 Telecomnet LLC
	  	Delaware
		
	 transact Elektronische Zahlungssysteme GmbH
	  	Germany
		
	 Universal Solution Providers FZ-LLC
	  	United Arab Emirates

  
 D-3Exhibit 10.1

 

	
         

        Notice of Grant of Stock Options

        And Option Agreement
	
        Hologic, Inc. 

        ID: 04-2902449

        35 Crosby Drive

        Bedford, MA 01730

        

 

 

 

	 	 
	Participant Name	Plan: 2008 Equity Incentive Plan (the “Plan”)	 
	 	 

         
	 
	 	 	 

 

 

 

Effective Grant
Date, you have been granted a Non-Qualified Stock Option (the “Option”) to buy shares
granted shares of Hologic, Inc. (the “Company”) common stock at grant
price. The Option is granted pursuant to the terms and conditions of the Plan, referenced above, and the option agreement
(the “Option Agreement”) provided herewith.

 

Subject to the terms and conditions of the Option Agreement
and the Plan, the Option will vest 20% on each of the first five anniversaries of the grant date, such that the Option will be
fully vested on the fifth anniversary of the grant date. Unless sooner terminated pursuant to the terms of the Option Agreement
or the Plan the Option will expire on Expiration
Date [10 years after grant date].

 

By your signature and the Company's signature below, you and
the Company agree that the Option is granted under and governed by the terms and conditions of the Plan and the Option Agreement.

 

 

 

	 	 
	 	 	 	 
	Hologic, Inc.	Date
	 	 
	 	 	 	 
	Electronic Signature	Acceptance Date

 

    	-1-

    	 

    

 

HOLOGIC, INC. 

 

NON-QUALIFIED STOCK OPTION AGREEMENT

 

 

Non Qualified Stock
Option Agreement (the “Option Agreement”) pursuant to the Hologic, Inc. 2008 Equity Incentive Plan, as it may be amended
from time to time (the “Plan”).

 

W I T N E S S E T H:

 

WHEREAS, the Company
and the Optionee desire to enter into an agreement whereby the Company will grant the Optionee an option (the “Option”)
to purchase shares of the Company’s Common Stock, $.01 par value per share (the “Common Stock”), as set forth
in the Notice of Grant of Stock Options to which this Award Agreement is attached (the “Award Notice”); and

 

WHEREAS, this Option
is intended to qualify as a “Non-Qualified Stock Option”, which is a stock option which does not qualify as an incentive
stock option under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”).

 

NOW THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Optionee agree
as follows:

 

1.Grant of Option.

 

Pursuant to the terms
and conditions of this Option Agreement and the Plan (which is incorporated herein by reference), the Company hereby grants to
the Optionee an Option to purchase shares of Common Stock (the “Option Shares”) as provided in the Award Notice. The
exercise price at which the Option Shares may be purchased (the “Option Exercise Price”) and the vesting schedule of
the Option are set forth in the Award Notice. The number and class of securities, vesting schedule and exercise price per share
subject to this Option are subject to adjustment as set forth in the Plan. In the event of a conflict between the terms and conditions
of the Plan and this Option Agreement, the terms and conditions of the Plan shall prevail. Capitalized terms used herein and not
otherwise defined shall have the meanings set forth in the Plan.

 

2.Vesting of
Option.

 

Subject to the provisions
of the Plan, Section 3 of this Option Agreement and the right of the Company to accelerate the date upon which any or all of this
Option would otherwise become exercisable, the Optionee shall be entitled to exercise this Option with respect to all or a portion
of the percentage or number of the Option Shares provided in the Award Notice. Notwithstanding the foregoing, in the event
that the Optionee’s Service (as defined below) is terminated as a result of the death or Permanent Disability (as defined
in Section 23(e)(3) of the Code) of the Optionee, the Option shall become fully vested upon such termination. For
purposes of this Agreement, the term “Service” shall mean service as a Service Provider to the Company, and the term
“Service Provider” shall mean an employee, officer or director of the Company or an Affiliate of the Company, or a
consultant currently providing services to the Company or an Affiliate of the Company. Whether a termination of Service shall have
occurred for purposes of this Agreement shall be determined by the Company, which determination shall be final, binding and conclusive.

  

Notwithstanding any
provision of this Option Agreement to the contrary, in no event may this Option be exercised after the Expiration Date set forth
in the Award Notice.

 

3.Termination
of Service.

 

If the Optionee’s
Service is terminated (a “Termination”), then unless otherwise provided in this Option Agreement or the Plan, this
Option may be exercised as to all shares with respect to which Optionee could exercise this Option on the date of Termination,
and which shares have not been previously purchased, until the earlier of the Expiration Date, or:

 

		(i)	in the case of a Termination by reason of death or Permanent Disability, one year after such Termination;
and

		(ii)	in all other cases, ninety (90) days after the Termination; or

 

such other date as determined by the Company,
and there shall be no further vesting of the Option after such Termination.

 

Notwithstanding the foregoing, in the case
of a Termination for cause, the ability to exercise this Option may be terminated on such earlier date as the Company may specify,
and such date may be set so as to prevent the Optionee from further exercising any portion of this Option.

 

    	-2-

    	 

    

  

4.Nontransferability;
Persons Able to Exercise.

 

The Option may not
be transferred other than by will or the laws of descent and distribution. During the life of the Optionee, only the Optionee may
exercise this Option. If the Optionee dies while still employed by the Company, or the periods specified in Section 3, this Option
may be exercised by the Optionee’s executors, administrators, legatees or distributees, provided that such person or persons
comply with the provisions of this Option applicable to the Optionee.

 

5.Method of
Exercising Option.

 

The Option may be exercised,
in whole or in part, by written notice to the Company, containing an executed Notice of Exercise in the form of Attachment A, provided
that the Company, in its discretion, may modify or augment these requirements as provided in Section 7 of this Option Agreement,
or where appropriate because a person other than the Optionee is exercising the Option pursuant to Section 4. The written notice
specified in this Section must be accompanied by payment of the Option Exercise Price for the shares being purchased. Payment shall
be made in cash, unless the Company, in its sole discretion, authorizes payment to be made in shares of Common Stock of the Company,
a combination of such shares and cash. As soon as practical after receipt of this notice and payment, the Company shall deliver
the purchased Option Shares. In the event this Option is exercised by any person other than the Optionee, the notice shall be accompanied
by appropriate proof of the right of such person to exercise this Option.

 

 

6.No Rights
Other Than Those Expressly Created.

 

Neither this Option,
the Option Agreement nor any action taken hereunder shall be construed as (i) giving the Optionee any right to be retained in the
Service of, or continue to be affiliated with, the Company, (ii) giving the Optionee any equity or interest of any kind in any
assets of the Company, or (iii) creating a trust of any kind or a fiduciary relationship of any kind between the Optionee and the
Company. As to any claim for any unpaid amounts under this Option, any person having a claim for payments shall be an unsecured
creditor. The Optionee shall not have any of the rights of a stockholder with respect to any Option Shares until such time as this
Option has been exercised and Option Shares have been issued.

 

7.Compliance
with Laws.

 

(a)Withholding
of Taxes. Pursuant to applicable federal, state, local or foreign laws, the Company may be required to collect or withhold
income or other taxes from Optionee upon the grant of this Option, the exercise of this Option, or at some other time. The Company
may require, as a condition to the exercise of this Option, or demand, at such other time as it may consider appropriate, that
the Optionee pay the Company the amount of any taxes which the Company may determine is required to be collected or withheld, and
the Optionee shall comply with the requirement or demand of the Company.

 

    	-3-

    	 

    

 

(b)Securities
Law Compliance. Upon exercise (or partial exercise) of this Option, the Optionee shall make such representations and furnish
such information as may, in the opinion of counsel for the Company, be appropriate to permit the Company to issue or transfer the
Option Shares in compliance with the provisions of applicable federal or state securities laws. The Company, in its discretion,
may postpone the issuance and delivery of Option Shares upon any exercise of this Option until completion of such registration
or other qualification of such shares under any federal or state laws, or stock exchange listing, as the Company may consider appropriate.
In addition, the Company may require that prior to the issuance or transfer of Option Shares upon exercise of this Option, the
Optionee enter into a written agreement to comply with any restrictions on subsequent disposition that the Company deems necessary
or advisable under any applicable federal and state securities laws. The Option Shares issued hereunder may be legended to reflect
such restrictions.

 

(c)General. No Option Shares
shall be issued upon exercise of this Option unless and until the Company is satisfied, in its sole discretion, that there has
been compliance with all legal requirements applicable to the issuance of such Option Shares.

 

 

8.Miscellaneous.

 

(a)Non-Qualified
Option. The Option hereby granted is not intended to be an “incentive stock option” as that term is defined in
Section 422 of the Internal Revenue Code.

 

(b).Recoupment/Claw-Back
of Awards. Notwithstanding any other provision of this Option Agreement to the contrary, any Option granted under this Option
Agreement (including any proceeds, gains or other economic benefit actually or constructively received upon any receipt or exercise
of any Option or upon the receipt or resale of any share of Common Stock underlying the Option) shall be subject to the terms of
any compensation recoupment or claw-back policy implemented by the Company, as any such policy may be amended from time to time,
and/or subject to recoupment as required by any other provisions of any law (including, without limitation, Section 10D of the
Securities Exchange Act of 1934, as amended), government regulation or stock exchange listing requirement.

 

(c)Discretion
of the Committee. Unless otherwise explicitly provided herein, the Board of Directors of the Company, or an authorized committee
thereof, shall make all determinations required to be made hereunder, including determinations required to be made by the Company,
and shall interpret all provisions of this Option and Option Agreement, as it deems necessary or desirable, in its sole and unfettered
discretion. Such determinations and interpretations shall be binding on and conclusive to the Company and the Optionee.

  

(d)Amendment.
This Option may only be modified or amended by a writing signed by both parties.

 

(e)Notices.
Any notices required to be given under this Option shall be sufficient if in writing and if sent by certified mail, return receipt
requested, and addressed as follows:

 

if to the Company:

 

Hologic, Inc.

35 Crosby Dr.

Bedford, MA 01730

Attention: Chief Financial Officer

 

if to the Optionee:

 

As set forth in the records of
the Company

 

or to such other address as either party may designate under
the provisions hereof.

 

(f)Entire Agreement.
This Option Agreement shall supersede in its entirety all prior undertakings and agreements of the Company and Optionee, whether
oral or written, with respect to this option; provided however that nothing herein shall supersede any prior written employment
or other similar written agreement, if any, that may provide, in certain circumstances, for acceleration or extension of options
granted to the Optionee.

 

    	-4-

    	 

    

 

(g)Successors
and Assigns. The rights and obligations of the Company under this Option Agreement shall inure to the benefit of and be binding
upon the successors and assigns of the Company.

 

(h)Applicable
Law; Severability. All rights and obligations under this Option Agreement shall be governed by the laws of the State of Delaware.
In the event that any court of competent jurisdiction shall determine that any provision, or any portion thereof, contained in
this Option Agreement shall be unenforceable in any respect, then such provision shall be deemed limited to the extent that such
court deems it enforceable, and as so limited shall remain in full force and effect. In the event that such court shall deem any
such provision, or portion thereof, wholly unenforceable, the remaining provisions of this Option Agreement shall nevertheless
remain in full force and effect. 

 

(i)Paragraph
Headings; Rules of Construction. The paragraph headings used in this Option Agreement are for convenience of reference, and
are not to be construed as part of this Option or Option Agreement. The parties hereto acknowledge and agree that the rule of construction
to the effect that any ambiguities are resolved against the drafting party shall not be employed in the interpretation of this
Option Agreement.

 

(j)Electronic
Copies. The Company may choose to deliver certain materials relating to the Plan in electronic form. By accepting this option,
you consent and agree that the Company may deliver the Plan prospectus and the Company’s annual report to you in an electronic
format. If at any time you would prefer to receive paper copies of these documents, as you are entitled to, the Company would be
pleased to provide you with such copies upon request.

 

(k).No Waiver of Rights, Powers and
Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under this Option Agreement, and no
course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy of the party, unless
explicitly provided for herein. No single or partial exercise of any right, power or remedy under this Option Agreement by a party
hereto, nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from
any other or further exercise thereof or the exercise of any other right, power or remedy hereunder.

 

(l). Counterparts.
The Award Notice to which this Option Agreement is attached and incorporated by reference may be executed in multiple counterparts,
including by electronic or facsimile signature, each of which shall be deemed in original but all of which together shall constitute
one and the same instrument.

 

    	-5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]